| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $299.3M | +19.8% |
| Gross Profit | -$230.4M | -7.6% |
| R&D Expense | $158.1M | -24.1% |
| SG&A Expense | $191.2M | -3.8% |
| Operating Income | -$916.5M | -41.0% |
| Pre-tax Income | -$956.5M | -12.8% |
| Income Tax | $71K | +491.7% |
| Net Income | -$958.2M | +0.8% |
| EPS (Basic) | -$17.56 | -1351.2% |
| EPS (Diluted) | -$17.56 | -1351.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $104.3M | -77.6% |
| Accounts Receivable | $33.4M | +85.7% |
| Inventory | $71.8M | +14.8% |
| Current Assets | $265.1M | -53.7% |
| Total Assets | $596.2M | -53.2% |
| Current Liabilities | $245.4M | -5.7% |
| Long-term Debt | $192.7M | -28.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$521.5M | -5.1% |
| Capital Expenditures | $47.0M | -61.0% |
| Investing Cash Flow | -$25.2M | +62.2% |
| Financing Cash Flow | $174.4M | -76.5% |
| Free Cash Flow | -$568.5M | +7.8% |
| Total Liabilities |
| $488.8M |
| -12.0% |
| Stockholders' Equity | $107.4M | -85.1% |